Notes on verification

Confirmed by EMA and FDA regulatory documents, manufacturer (Roche) product information, and recent financial disclosures showing ongoing marketing for oncology indications. [tier=gold indep_score=0.92 clusters=5 claim_tier=everyday | framework convergence=partial (upstreams: European Medicines Agency (EMA) EPAR, U.S. FDA drug labeling/prescribing information, Roche corporate financial disclosures) — publishers independent, evidence may not be | kind=empirical eligibility=high]